A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Public ClinicalTrials.gov record NCT06657768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, PK and PD of LY4006895 in Healthy Volunteers and Patients With Early Symptomatic AD
Study identification
- NCT ID
- NCT06657768
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Interventions
- LY4006895 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 28, 2024
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
- Last update posted
- Mar 26, 2026
2024 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network - CNS | Los Alamitos | California | 90720 | Recruiting |
| K2 Medical Research - The Villages | Lady Lake | Florida | 32159 | Recruiting |
| K2 Medical Research | Maitland | Florida | 32751 | Recruiting |
| Atlanta Center of Medical Research | Atlanta | Georgia | 30331 | Recruiting |
| CenExel iResearch, LLC (CenExel iRA) | Decatur | Georgia | 30030 | Recruiting |
| CenExel-HRI | Marlton | New Jersey | 08053 | Recruiting |
| Duke Early Phase Research Unit | Durham | North Carolina | 27710 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06657768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06657768 live on ClinicalTrials.gov.